COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Clinical trial NCT06372457 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06372457
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-01
- Primary completion
- 2025-09-29
- Enrollment
- 331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.